Table 5 Reported adverse events among the study cohort
|  | SOF/VEL + RBV (n = 75) | SOF/VEL/VOX (n = 75) |
|---|---|---|
Mild adverse events | ||
 Headache | 1 | 4 |
 Vertigo | 0 | 4 |
 Abdominal colics | 1 | 2 |
 Thrombocytopenia | 1 | 1 |
 Hair loss | 0 | 1 |
 Vomiting | 0 | 1 |
 Arthralgia | 0 | 1 |
 Hyperbilirubinemia | 9 | 0 |
 Anemia | 3 | 0 |
 Easy fatiguability | 1 | 0 |
 Dark skin | 1 | 0 |
Moderate adverse events | ||
 Anemia | 1 | 0 |